Next Article in Journal
Previous Article in Journal
Pharmaceuticals 2012, 5(12), 1282-1290; doi:10.3390/ph5121282
Article

Synthesis and COX-2 Inhibitory Activity of 4-[(E)-2-(4-Oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethenyl]benzene-1-sulfonamide and Its Analogs

1,* , 2
, 3
 and 1
Received: 11 October 2012; in revised form: 14 November 2012 / Accepted: 23 November 2012 / Published: 27 November 2012
View Full-Text   |   Download PDF [224 KB, uploaded 27 November 2012]
Abstract: Some novel 3-phenyl-2-[(E)-2-phenylethenyl]-3,4-dihydroquinazolin-4-one derivatives possessing para-sulfonamides groups on the phenyl ring of the 2-phenylethenyl moiety have been synthesized and their COX-2 inhibitory activity evaluated. The stuctures of the synthesized compounds were confirmed  on the basis of  FT-IR, 1H-NMR, 13C-NMR and mass spectral data. The COX-2 inhibition screening assay revealed that 4-[(E)-2-{3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl}ethenyl]benzene-1-sulfonamide had a  maximum COX-2 inhibition (47.1%), at a concentration of 20 μM.
Keywords: quinazolin-4-one; benzenesulfonamide; COX-2 inhibitor quinazolin-4-one; benzenesulfonamide; COX-2 inhibitor
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Hayun; Hudiyono, S.; Hanafi, M.; Yanuar, A. Synthesis and COX-2 Inhibitory Activity of 4-[(E)-2-(4-Oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethenyl]benzene-1-sulfonamide and Its Analogs. Pharmaceuticals 2012, 5, 1282-1290.

AMA Style

Hayun, Hudiyono S, Hanafi M, Yanuar A. Synthesis and COX-2 Inhibitory Activity of 4-[(E)-2-(4-Oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethenyl]benzene-1-sulfonamide and Its Analogs. Pharmaceuticals. 2012; 5(12):1282-1290.

Chicago/Turabian Style

Hayun; Hudiyono, Sumi; Hanafi, Muhammad; Yanuar, Arry. 2012. "Synthesis and COX-2 Inhibitory Activity of 4-[(E)-2-(4-Oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethenyl]benzene-1-sulfonamide and Its Analogs." Pharmaceuticals 5, no. 12: 1282-1290.



Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert